BR112012006628A2 - compostos antivírus heterocíclos - Google Patents

compostos antivírus heterocíclos

Info

Publication number
BR112012006628A2
BR112012006628A2 BR112012006628A BR112012006628A BR112012006628A2 BR 112012006628 A2 BR112012006628 A2 BR 112012006628A2 BR 112012006628 A BR112012006628 A BR 112012006628A BR 112012006628 A BR112012006628 A BR 112012006628A BR 112012006628 A2 BR112012006628 A2 BR 112012006628A2
Authority
BR
Brazil
Prior art keywords
antivirus
heterocycle
compounds
heterocycle antivirus
antivirus compounds
Prior art date
Application number
BR112012006628A
Other languages
English (en)
Inventor
Chris Allen Broka
David Bernard Smith
Hans Maag
Jutta Wanner
Robert Than Hendricks
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR112012006628A2 publication Critical patent/BR112012006628A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112012006628A 2009-09-24 2010-09-21 compostos antivírus heterocíclos BR112012006628A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24549709P 2009-09-24 2009-09-24
PCT/EP2010/063832 WO2011036128A1 (en) 2009-09-24 2010-09-21 Heterocyclic antiviral compounds

Publications (1)

Publication Number Publication Date
BR112012006628A2 true BR112012006628A2 (pt) 2016-05-03

Family

ID=43033086

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012006628A BR112012006628A2 (pt) 2009-09-24 2010-09-21 compostos antivírus heterocíclos

Country Status (11)

Country Link
US (1) US20110070190A1 (pt)
EP (1) EP2480556A1 (pt)
JP (1) JP2013505912A (pt)
KR (1) KR20120079111A (pt)
CN (1) CN102510864A (pt)
AU (1) AU2010299928A1 (pt)
BR (1) BR112012006628A2 (pt)
CA (1) CA2768523A1 (pt)
IL (1) IL217343A0 (pt)
MX (1) MX2012002958A (pt)
WO (1) WO2011036128A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100260825A1 (en) * 2009-04-13 2010-10-14 Nair Madhavan G Antifolates for the treatment of cardiovascular, inflammatory, neoplastic, autoimmune and related diseases in sublingual dosage units, film strips, or skin patches
AU2016270903B2 (en) 2015-06-03 2020-04-30 Bristol-Myers Squibb Company 4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists for use in the treatment of cardiovascular disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004065392A1 (en) * 2003-01-24 2004-08-05 Smithkline Beecham Corporation Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands
MX2007004783A (es) * 2004-10-21 2007-05-11 Pfizer Inhibidores de la proteasa del virus de la hepatitis c, y composiciones y tratamientos que los usan.
US20090030196A1 (en) * 2006-12-29 2009-01-29 Abbott Laboratories Pim kinase inhibitors as cancer chemotherapeutics
CN101910145A (zh) * 2008-02-14 2010-12-08 弗·哈夫曼-拉罗切有限公司 抗病毒的杂环化合物

Also Published As

Publication number Publication date
JP2013505912A (ja) 2013-02-21
EP2480556A1 (en) 2012-08-01
WO2011036128A1 (en) 2011-03-31
IL217343A0 (en) 2012-02-29
US20110070190A1 (en) 2011-03-24
KR20120079111A (ko) 2012-07-11
MX2012002958A (es) 2012-04-19
CN102510864A (zh) 2012-06-20
CA2768523A1 (en) 2011-03-31
AU2010299928A1 (en) 2012-02-02

Similar Documents

Publication Publication Date Title
CY2017026I1 (el) Τετρακυκλικη ενωση
SMT201600008B (it) Composti di piridazinone
CY2016001I2 (el) Αντι-ιικες ενωσεις
BR112012006859A2 (pt) compostos
DK2427449T3 (da) Vinylindazolylforbindelser
BRPI1012247A2 (pt) compostos inseticidas
BRPI1015931A2 (pt) Compostos inseticidas
BRPI1013614A2 (pt) compostos substituídos de espiro-amida
BRPI1008774A2 (pt) espiroamida substituída
BRPI1005525A2 (pt) compostos de azaazuleno
DK2540728T3 (da) Heterocyklisk forbindelse
ECSP12011999A (es) Derivados benzamida sustituidos
BRPI1013868A2 (pt) composto diaciletilenodiamina
DK2397480T3 (da) Diazepindionderivat
BR112012003868A2 (pt) Compostos orgânicos
BRPI1013941A2 (pt) compostos inseticidas
UY33156A (es) Nuevos compuestos tienopirrol
DK2387580T3 (da) Deoxyactagardinderivater
DK2427454T3 (da) Heterocykliske phenoxymethylforbindelser
BR112013010643A2 (pt) compostos heterocíclicos
BR112012010238A2 (pt) compostos heterocíclicos pesticidas
ES1070429Y (es) Traspaleta mejorada
BR112013010270A2 (pt) polimorfos de febuxostato
BRPI1009199A2 (pt) compostos de pirazinoisoquinolina
BR112012006628A2 (pt) compostos antivírus heterocíclos

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]